Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy

被引：0
|
作者：
Zhiwei Cui
Fan Zou
Rongli Wang
Lijun Wang
Feiyan Cheng
Lihui Wang
Rumeng Pan
Xin Guan
Nini Zheng
Wei Wang
机构：
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Obstetrics and Gynecology
[2] Affiliated Hospital of Zunyi Medical University,Department of Respiratory and Critical Care Medicine
[3] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Anesthesiology
来源：
World Journal of Surgical Oncology | / 21卷
关键词：
WDHD1; Pan-cancer; Prognosis; Diagnosis; Tumor immunity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3
    Wu, Yinteng
    Zhang, Bo
    Nong, Juan
    Rodriguez, Raquel Alarcon
    Guo, Wenliang
    Liu, Ying
    Zhao, Shijian
    Wei, Ruqiong
    FRONTIERS IN GENETICS, 2023, 14
  • [42] Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
    Zhang, Nie
    He, Zhuoying
    Qin, Xuejin
    Han, Ke
    Zhu, Zhengchun
    Zhong, Fei
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [43] NEK2 is a potential pan-cancer biomarker and immunotherapy target
    Zhang, Lanyue
    Li, Yang
    Deng, Juexiao
    Liao, Wenxin
    Liu, Tingting
    Shen, Fujin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [44] Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
    Wang, Yuqi
    Yuan, Hongwei
    Yue, Genquan
    Zhao, Lingyan
    Xia, Yuan
    Zhang, Nan
    Li, Hailing
    Liu, Dongyang
    Su, Yubo
    Wang, Haisheng
    Gao, Yumin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
    Yuqi Wang
    Hongwei Yuan
    Genquan Yue
    Lingyan Zhao
    Yuan Xia
    Nan Zhang
    Hailing Li
    Dongyang Liu
    Yubo Su
    Haisheng Wang
    Yumin Gao
    Scientific Reports, 13
  • [46] CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer
    Yang, Kai
    Ma, Yan
    Chen, Weigang
    Liu, Lu
    Yang, Zelong
    He, Chaokui
    Zheng, Nanbei
    Liu, Xinyu
    Cheng, Xin
    Song, Junbo
    Chen, Yong
    Qiao, Hongyu
    Zhang, Ruohan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [47] Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
    Xu, Peiyi
    Zhang, Qiuyan
    Zhai, Jing
    Chen, Pu
    Deng, Xueting
    Miao, Lin
    Zhang, Xiuhua
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [48] A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
    Feng, Yan
    Tao, Fengying
    Qiao, Han
    Tang, Huaping
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
    Zhuang, Lingling
    Sun, Qiran
    Huang, Shenglan
    Hu, Lanyan
    Chen, Qi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [50] Comprehensive pan-cancer analysis of LAMAS: implications for prognosis and immunotherapy
    Huang, Hui
    Dong, Wei
    Qin, Xuan
    Usama, Ali
    Cheema, Anees
    Deng, Chunlei
    Sarfaraz, Sara
    Pan, Qingyun
    Alhomrani, Majid
    Alamri, Abdulhakeem S.
    Alsuhaymi, Naif
    Alghamdi, Saleh A.
    Alghamdi, Ahmad A.
    Zheng, Su
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2025, 17 (02):
12345